How do I apply for Biomedical Translation Fund (BTF)?

Apply through the official government portal at https://business.gov.au/grants-and-programs/biomedical-translation-fund. Review eligibility criteria carefully before applying and ensure all supporting documents are prepared.

What type of funding is Biomedical Translation Fund (BTF)?

Biomedical Translation Fund (BTF) is a concessional loan (low-interest government financing).

Which states or regions can apply for Biomedical Translation Fund (BTF)?

Biomedical Translation Fund (BTF) is available to eligible businesses in all Australian states and territories.

Closed

Biomedical Translation Fund (BTF)

Funding

Up to $501,250,000

Region

Commonwealth

View Official Page

Overview

An equity co-investment venture capital program that provides early-stage biomedical companies with investment to develop and commercialise biomedical discoveries. The fund supports therapeutic, medical, pharmaceutical products, processes, services, technologies and procedures that improve health and wellbeing through targeted investment in prevention, diagnosis and treatment.

Eligibility Requirements

Early-stage biomedical companies with average annual revenue below $25 million per year, majority of employees and assets in Australia, ABN, incorporated under Corporations Act 2001, and working on or planning to work on biomedical discoveries. Investment decisions are made by 3 licensed private sector fund managers.

Who Can Apply

StartupsSme

Relevant Industries

HealthBiomedical

How to Apply

Applications are submitted through the official government portal. Review the eligibility criteria carefully before applying, and ensure all supporting documents are prepared.

Visit the official application page

Disclaimer: Grant information is sourced from official government websites and updated regularly. Always verify current eligibility and deadlines on the official program page before applying.

Early Stage Venture Capital Limited Partnerships (ESVCLPs)

A venture capital investment program that provides capital and professional expertise to innovative Australian early-stage companies and high-growth startups. The program offers increased fund sizes up to $200 million, a 10% tax offset on capital deployed into start-up companies, and a tax-exempt environment for investment returns.

Open·Commonwealth·$25,000,000

MRFF 2022 Frontier Health and Medical Research Grant Opportunity

This grant program supports researchers pursuing innovative projects to develop new products and interventions in health and medical research, with the goal of creating treatments for serious and incurable health conditions. Funding supports programs of research comprising linked projects with a 10-year time horizon, from proof-of-concept through to full clinical implementation.

Open·Commonwealth·Up to $2,000,000

MRFF – Traumatic Brain Injury Mission – 2026

This grant supports medical research and medical innovation projects aimed at improving outcomes for Australians with traumatic brain injury (TBI). Two streams are available: Stream 1 focuses on testing novel treatments and interventions for moderate to severe TBI, while Stream 2 supports research on implementing clinical guidelines and protocols for mild TBI with attention to equity and access across diverse populations.